Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Active not recruiting 2

Sponsor Class

NETWORK 2OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma 2Hodgkin Disease 2

Interventions

Specimen Handling 68Magnetic Resonance Spectroscopy 53Cyclophosphamide 45Vincristine 38Radiotherapy 31Radiation 31Cisplatin 31Carboplatin 30Dexamethasone 27Etoposide 26Biopsy 26Doxorubicin 25Prednisone 18daratumumab 17Radiotherapy, Intensity-Modulated 17durvalumab 16Platinum 16Paclitaxel 16Irinotecan 16Cytarabine 16Gemcitabine 151,2-diaminocyclohexaneplatinum II citrate 15Observation 14Methotrexate 14Leucovorin 14Docetaxel 14Lenalidomide 13X-Rays 12Watchful Waiting 12Rituximab 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Mechlorethamine × 1 year × Clear all
NCT00002462 2025-08-05

RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Active not recruiting
615 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT00379041 2025-08-05

Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Active not recruiting
1,158 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡